JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MARSH, D. F.
Right arrow Articles by PELLETIER, M. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by MARSH, D. F.
Right arrow Articles by PELLETIER, M. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 92, Issue 4, 454-458, 1948
Copyright © 1948 by American Society for Pharmacology and Experimental Therapeutics


THE CURARIFORM ACTIVITY OF d-N-METHYL-ISOCHON-DRODENDRINE AND d-O-METHYL-N-METHYL-ISOCHONDRODENDRINE

DAVID F. MARSH 1 and M. H. PELLETIER 1

1 Department of Pharmacology, West Virginia University School of Medicine, Morgantown

d-N-Methyl-isochondrodendrine iodide and d-O-methyl-N-methyl-isochondrodendrine iodide were compared with d-tubocurarine chloride pentahydrate and d-O-methyltubocurarine iodide trihydrate in rats, rabbits, and cats. d-N-Methyl-isochondrodendrine (as the ion) is about 1/20 and d-O-methyl-N-methyl-isochondrodendrine 1/4 as paralysant as d-tubocurarine, which in turn is only 1/10 as active as d-O-methyltubocurarine. Like the tubocurarine compounds, these isochondrodendrine derivatives have relatively little effect in intact animals other than lissive action on skeletal muscles.

Submitted on January 2, 1948







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1948 by the American Society for Pharmacology and Experimental Therapeutics.